Thomas S. McHugh
Chief Financial Officer · AVADEL PHARMACEUTICALS PLC
- 2024
- Feb 12, 2026
- 3
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Thomas S. McHugh files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Weiss Asset Management LP - $233.35M in AVDL purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Thomas S. McHugh?
Thomas S. McHugh is a corporate insider, tracked as Chief Financial Officer of AVADEL PHARMACEUTICALS PLC (AVDL). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Thomas S. McHugh last file a Form 4?
The most recent primary Form 4 on record is dated 12 February 2026, one of 3 filings going back to 2024.
Has Thomas S. McHugh been buying or selling stock?
Recorded transactions: 2 open-market purchases ($76K) and 0 open-market sales across all tracked filings.
